Inventor · disambiguated record
Jing Wang
Also filed as: WANG JING · WANG JING YANG · WERNER DOUGLAS S
17 granted patents·13 pending applications·108 citations·filing 2002–2023
92Inventor score
Top patents by PatentIndex Score
30 records- 0195US7700594B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2006·Granted Apr 20, 2010·38 cites·6 claims
- 0291US7923555B2Fused bicyclic mTor inhibitorsOSI PHARM INC·Filed 2008·Granted Apr 12, 2011·15 cites·2 claims
- 0389US8314111B2Fused bicyclic motor inhibitorsCHEN XIN·Filed 2011·Granted Nov 20, 2012·12 cites·2 claims
- 0488US7943767B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2009·Granted May 17, 2011·9 cites·14 claims
- 0587US8796455B2Fused bicyclic mTOR inhibitorsCHEN XIN·Filed 2013·Granted Aug 5, 2014·8 cites·10 claims
- 0681US7381736B2Thiazole and thiadiazole inhibitors of tyrosine phosphatasesMETABASIS THERAPEUTICS INC·Filed 2005·Granted Jun 3, 2008·7 cites·19 claims
- 0779US8481733B2Substituted imidazopyr- and imidazotri-azinesCREW ANDREW P·Filed 2009·Granted Jul 9, 2013·7 cites·16 claims
- 0879US7960428B2Enantiomerically pure phosphoindoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Jun 14, 2011·3 cites·42 claims
- 0975US8178668B22-aminopyridine kinase inhibitorsSTEINIG ARNO G·Filed 2009·Granted May 15, 2012·3 cites·9 claims
- 1071US9351974B2Substituted pteridinones for the treatment of cancerOSI PHARMACEUTICALS LLC·Filed 2012·Granted May 31, 2016·2 cites·10 claims
- 1170US8592448B2Substituted pyrrolo[2,3-b]-pyridines and -pyrazinesCHEN XIN·Filed 2009·Granted Nov 26, 2013·1 cites·18 claims
- 1270US8378104B27-aminofuropyridine derivativesOSI PHARMACEUTICALS LLC·Filed 2011·Granted Feb 19, 2013·2 cites·24 claims
- 1366US2025215055A1Secretion-optimized de novo designed protein nanoparticles for eukaryotic expression and genetic deliveryUNIV WASHINGTON·Filed 2023·Application pending·0 cites
- 1463US8445510B2Fused bicyclic kinase inhibitorsMULVIHILL MARK J·Filed 2011·Granted May 21, 2013·1 cites·15 claims
- 1557US2024277831A1Polypeptides, compositions, and their use to treat or limit development of an infectionUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1657US2011190496A1FUSED BICYCLIC mTOR INHIBITORSOSI PHARM INC·Filed 2011·Application pending·0 cites
- 1751US2008200371A1Thiazole and thiadiazole inhibitors of tyrosine phosphatasesCHERUVALLATH ZACHARIA S·Filed 2008·Application pending·0 cites
- 1850US12433943B2Nanoparticle-based influenza virus vaccines and uses thereofTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Oct 7, 2025·0 cites·30 claims
- 1950US8486991B2Enantiomerically pure phosphoindoles as HIV inhibitorsSTORER RICHARD·Filed 2011·Granted Jul 16, 2013·0 cites·22 claims
- 2050US8022206B2Furo[3,2-C]pyridinesOSI PHARMACEUTICALS LLC·Filed 2009·Granted Sep 20, 2011·0 cites·19 claims
- 2150US7595390B2Industrially scalable nucleoside synthesisNOVARTIS AG·Filed 2004·Granted Sep 29, 2009·0 cites·23 claims
- 2250US2023075095A1Polypeptides and their useUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 2349US2013253197A1Fused bicyclic kinase inhibitorsOSI PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 2446US2007129364A1Pyrrolopyridine kinase inhibiting compoundsDONG HAN-QING·Filed 2006·Application pending·0 cites
- 2543US2007208053A1Fused heterobicyclic kinase inhibitorsARNOLD LEE D·Filed 2007·Application pending·0 cites
- 2642US2014088114A1Fused bicyclic kinase inhibitorsJIN MEIZHONG·Filed 2012·Application pending·0 cites
- 2740US2012329826A1Substituted-5-aminopyrrolo/pyrazolopyridinesLI AN-HU·Filed 2011·Application pending·0 cites
- 2838US2006135483A1Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatasesCHERUVALLATH ZACHARIA S·Filed 2005·Application pending·0 cites
- 2936US2006135773A1Trisubstituted nitrogen modulators of tyrosine phosphatasesSEMPLE JOSEPH E·Filed 2005·Application pending·0 cites
- 3035US2005065118A1Organosulfur inhibitors of tyrosine phosphatasesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →